GLP-1, or glucagon-like peptide-1, is a hormone your body naturally produces in the gut
Answer: Cagrilintide is given as a once-weekly subcutaneous injection, typically self-administered at home after in-office training, with the dose titrated upward over several weeks to reach the target while minimizing nausea
By combining GLP-1 receptor agonism with glucagon receptor activation, it tackles both sides of the weight-loss equation: Less intake through appetite suppression and delayed gastric emptying More burn through increased energy expenditure and hepatic fat metabolism Early Phase 2 data showed double-digit weight loss (up to ~19%), improvements in glycemic control, and reductions in liver fat and fibrosis markers, suggesting its role may extend well beyond weight management into MASH treatment
The peptide also apparently reduced IL-1-driven phosphorylation of ERK1/2, JNK, and p38, pointing toward broad dampening of MAP kinase signaling
While NAC boosts glutathione production indirectly, direct glutathione supplements offer immediate support